Current Edition

08. Centralised Monitoring - A Smart...
Editorial Archive

Centralised Monitoring: A Smart and Cost-efficient Approach

The clinical monitoring cost is one of the major costs and accounts for one-third of the overall cost of clinical trial management. As the complexities …

Continue Reading →
07. Cardiac Safety Investigations...
Editorial Archive

Cardiac Safety Investigations 10 Years after ICH Guidance E14: – Evolving Industry and Regulatory Viewpoints on Evaluation of Proarrhythmic Risk during New Drug Development

The year 2015 marks the 10th anniversary of the release of two ICH Harmonised Tripartite Guidelines that have governed the cardiac safety regulatory landscape, more …

Continue Reading →
06. Overcoming Regulatory Challenges...
Editorial Archive

Overcoming Regulatory Challenges in Cognitive Drug Development

In recent years, numerous pharmaceutical and biotechnology companies have undertaken development programmes intended to assess the efficacy of various pro-cognitive drugs on a wide variety …

Continue Reading →